LISA PORADZISZ: Open Payments
NPI 1619448735 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,111 in 120 payments from 22 companies in 2025. Trend: 2023 $2,436 · 2024 $2,178 · 2025 $2,111
Food & beverage: $2,111
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $263 |
| Amneal Pharmaceuticals LLC | 17 | $232 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $222 |
| Madrigal Pharmaceuticals | 4 | $211 |
| RECORDATI_RARE_DISEASES_INC. | 13 | $181 |
| Corcept Therapeutics | 10 | $153 |
| ABBVIE INC. | 9 | $141 |
| Novo Nordisk Inc | 10 | $139 |
| Amgen Inc. | 5 | $98 |
| Acella Pharmaceuticals, LLC | 4 | $76 |
Products named: JARDIANCE, UNITHROID, MOUNJARO, REZDIFFRA, ISTURISA, Korlym, REPATHA, SYNTHROID.
Industry payments across IN — which companies pay providers there.
